Related Experiment Video
Updated: Jun 27, 2025
05:02
Modeling Brain Metastasis Via Tail-Vein Injection of Inflammatory Breast Cancer Cells
Published on: February 4, 2021
3.3K
PMS2 amplification contributes brain metastasis from lung cancer
Jianing Chen1, Congli Hu1, Hainan Yang1,2
1Department of Medical Oncology, Shanghai Pulmonary Hospital &, Thoracic Cancer Institute, Tongji University School of Medicine, Shanghai, China.
Biological Procedures Online
|May 7, 2024
Summary
PMS2 amplification drives brain metastasis in lung adenocarcinoma. This gene enhances tumor cell migration and invasion, impacting patient survival through altered metabolism pathways.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Lung adenocarcinoma brain metastasis significantly increases patient mortality.
- Understanding the mechanisms of brain metastasis is crucial for improving survival rates.
Purpose of the Study:
- To identify genes driving brain metastasis in lung adenocarcinoma.
- To investigate the role of PMS2 amplification in lung cancer brain metastasis.
Main Methods:
- Targeted gene sequencing of cerebrospinal fluid and plasma from 114 patients.
- In vitro (wound healing, migration assays) and in vivo (mouse brain colonization) studies of PMS2-amplified cell lines.
- RNA sequencing to compare gene expression between PMS2-amplified and wild-type cells.
Main Results:
- PMS2 amplification identified as a potential driver of brain metastasis.
- PMS2-amplified lung cancer cells exhibited enhanced migration and invasion capabilities.
- Metabolic pathways (thiamine, butanoate, glutathione) were enriched in PMS2-amplified cells.
Conclusions:
- Elevated PMS2 expression in tumor cells enhances lung cancer's metastatic potential to the brain.
- PMS2 amplification contributes to brain colonization through modulation of specific metabolism pathways.
